Sevda Sehzade

Sevda Sehzade

Auto-generated profile, based on publicly available information

Sevda Sehzade

Department of Medicine-Physiology, Bursa Uludag University Graduate School of Health Sciences, Bursa, Türkiye

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2026 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SSSevda Sehzade
Sevda Sehzade
ACAysen Cakir
Aysen Cakir
CKCansu Koc
Cansu Koc
NKNevzat Kahveci
Nevzat Kahveci

18 February 2026 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
AÇA. Çakır
A. Çakır
SŞS. Şehzade
S. Şehzade
CKC. Koç
C. Koç
SCSumeyye Cilingir
Sumeyye Cilingir
DADilan Acar
Dilan Acar
NKN. Kahveci
N. Kahveci
REM sleep deprivation (REMSD) contributes to neurodegenerative diseases like Alzheimer’s Disease (AD). This study examined REMSD’s effects on cognition, ER stress, and AD-like pathology in rats, alongside melatonin’s therapeutic potential. REMSD was induced for six days using the modified multiple platform method (MMPM). Cognitive function was tested via the Morris Water Maze (MWM). Rats received melatonin (20 mg/kg), 4-PBA (as a positive control, 100 mg/kg), or vehicle during deprivation/recovery periods. Western blotting and ELISA assessed ER stress markers (BiP, pIRE1, pPERK, peIF2-α, CHOP and GRP94, GADD34), Alzheimer related molecules (Aβ40/42, Tau, APP, GSK3β) and apoptosis-related proteins (Caspase 2, Caspase 12, BAX/Bcl-2). In addition, the mRNA expression levels of ATF4 and ATF6 were determined by PCR. Recovery sleep restored cognition, but melatonin/4-PBA enhanced it further. REMSD was associated with increased ER stress and AD-like pathology, whereas melatonin and 4-PBA appeared to attenuate these alterations, possibly by influencing the unfolded protein response (UPR) and reducing protein misfolding. Melatonin shows promise in countering SD-associated neurodegeneration, highlighting sleep’s role in proteostasis and its potential clinical use in AD and protein-misfolding disorders.